Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Dolzhikova, Inna V
118  Ergebnisse:
Personensuche X
?
1

New conjugates based on N4-hydroxycytidine with more potent..:

Siniavin, Andrei E. ; Gushchin, Vladimir A. ; Shastina, Natal'ya S....
Antiviral Research.  225 (2024)  - p. 105871 , 2024
Link: https://doi.org/10.1016/..
 
?
2

In Vitro Efficacy of Antivirals and Monoclonal Antibodies a..:

Pochtovyi, Andrei A. ; Kustova, Daria D. ; Siniavin, Andrei E....
Vaccines.  11 (2023)  10 - p. 1533 , 2023
Link: https://doi.org/10.3390/..
 
?
3

Vaccines to prevent Ebola virus disease: current challenges..:

Kovyrshina, Anna V. ; Sizikova, Tatiana E. ; Lebedev, Vitaliy N....
Problems of Virology.  68 (2023)  5 - p. 372-384 , 2023
Link: https://doi.org/10.36233..
 
?
4

Real-world clinical effectiveness of Tixagevimab/Cilgavimab..:

Fomina, Daria S. ; Lebedkina, Marina S. ; Iliukhina, Anna A....
Frontiers in Immunology.  14 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
5

Safety and immunogenicity of rAd26 and rAd5 vector-based he..:

Tukhvatulin, Amir I. ; Dolzhikova, Inna V. ; Dzharullaeva, Alina S....
Frontiers in Immunology.  14 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
6

rAAV expressing recombinant antibody for emergency preventi..:

Esmagambetov, Ilias B. ; Ryabova, Ekaterina I. ; Derkaev, Artem A....
Frontiers in Immunology.  14 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
7

Fast and Accurate Surrogate Virus Neutralization Test Based..:

Kolesov, Denis E. ; Sinegubova, Maria V. ; Dayanova, Lutsia K....
Diagnostics.  12 (2022)  2 - p. 393 , 2022
Link: https://doi.org/10.3390/..
 
?
8

COVID-19 vaccination and HIV-1 acquisition:

Logunov, Denis Y ; Livermore, David M ; Ornelles, David A...
The Lancet.  399 (2022)  10333 - p. e34-e35 , 2022
Link: https://doi.org/10.1016/..
 
?
9

Retention of Neutralizing Response against SARS-CoV-2 Omicr..:

Lapa, Daniele ; Grousova, Daria M. ; Matusali, Giulia...
Vaccines.  10 (2022)  5 - p. 817 , 2022
Link: https://doi.org/10.3390/..
 
?
10

Immunogenicity and protectivity of intranasally delivered v..:

Tukhvatulin, Amir I. ; Gordeychuk, Ilya V. ; Dolzhikova, Inna V....
Emerging Microbes & Infections.  11 (2022)  1 - p. 2229-2247 , 2022
Link: https://doi.org/10.1080/..
 
?
11

Single-Domain Antibodies Efficiently Neutralize SARS-CoV-2 ..:

Favorskaya, Irina A. ; Shcheblyakov, Dmitry V. ; Esmagambetov, Ilias B....
Frontiers in Immunology.  13 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
12

Estimation of anti-orthopoxvirus immunity in Moscow residen..:

Gushchin, Vladimir A. ; Ogarkova, Darya A. ; Dolzhikova, Inna V....
Frontiers in Immunology.  13 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
13

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2..:

Molodtsov, Ivan A ; Kegeles, Evgenii ; Mitin, Alexander N...
Clinical Infectious Diseases.  75 (2022)  1 - p. e1-e9 , 2022
Link: https://doi.org/10.1093/..
 
?
14

SARS-CoV-2 evolution in a patient with secondary B-cell imm..:

Mukhina, Olgo A. ; Fomina, Daria S. ; Parshin, Vasiliy V....
Human Vaccines & Immunotherapeutics.  18 (2022)  6 - p. , 2022
Link: https://doi.org/10.1080/..
 
?
15

Impact of pathogen reduction methods on immunological prope..:

Kostin, Alexander I. ; Lundgren, Maria N. ; Bulanov, Andrey Y....
Vox Sanguinis.  116 (2021)  6 - p. 665-672 , 2021
Link: https://doi.org/10.1111/..
 
1-15